Donna Lopolito spent 13 years as a CFO in the life sciences arena at PricewaterhouseCoopers, so she was a good pick when HepaLife Technologies Inc. tapped her to be its top financial guru.
The Boston-based artificial liver developer hired Lopolito in February. She’s a CPA with full-time or interim CFO stints at Codon Devices, Genocea, Interleukin Genetics, Modular Genetics, Organogenesis and InfraReDx under her belt.